Form 4: Zoetis Director Gregory Norden Reports Stock Transactions

Zoetis Inc. Director Gregory Norden reported the vesting of restricted stock units and subsequent stock transactions, including a sale for tax purposes.

Summary

• Gregory Norden, a Director of Zoetis Inc. (ZTS), reported transactions related to his beneficial ownership of company stock.
• On February 19, 2026, Norden acquired 1,619 shares of common stock upon the vesting and settlement of restricted stock units (RSUs).
• Concurrently, Norden disposed of 406 shares of common stock back to Zoetis Inc. for cash at a price of $127.28 per share, likely for tax withholding purposes.
• Following these transactions, Norden directly owns 1,213 shares of common stock.
• Indirect beneficial ownership includes 5,858.1922 shares via a personal trust, 5,548 shares via a daughter's trust, and 5,548 shares via a son's trust.
• The RSUs were granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions related to equity compensation, which is a standard part of director remuneration and does not indicate a significant change in company outlook or strategy.

Positives

• The vesting of restricted stock units indicates the fulfillment of equity compensation plans, aligning director interests with shareholder value.

Negatives

• The disposition of 406 shares, while common for tax withholding, represents a reduction in direct ownership.

Future Outlook

The filing indicates that additional restricted stock units will vest and be settled in shares of Zoetis Inc. common stock on February 18, 2026, subject to the reporting person's continued service.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive and director stock ownership changes. These transactions, particularly those related to RSU vesting and tax withholding, are common across publicly traded companies as part of standard equity compensation practices.

Comparison to Industry Standards

• The RSU vesting and subsequent sale for tax purposes are standard practices in executive compensation across various industries, including the pharmaceutical and animal health sectors. This type of transaction is a common mechanism for insiders to realize value from their equity awards while covering tax obligations.

Related Party Transactions

• Disposition of 406 shares to Zoetis Inc. by Director Gregory Norden in exchange for cash, likely for tax withholding related to RSU vesting.

Stakeholder Impact

• Shareholders: Provides transparency into director stock ownership and compensation practices.
• Employees: Reflects standard equity compensation mechanisms for key personnel.

Next Steps

• Vesting and settlement of remaining restricted stock units on February 18, 2026.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to the vesting of restricted stock units and a subsequent sale for tax purposes. Such transactions are standard and generally do not provide new material information to warrant a change in investment recommendation. The core business fundamentals of Zoetis Inc. remain the primary drivers for any investment decision, which are not addressed in this filing.

Keywords

Zoetis Inc., ZTS, Form 4, Insider Trading, Restricted Stock Units, Equity Compensation, Director Transactions, Stock Ownership